Sanguine Therapeuticz Private Limited Company Logo

Sanguine Therapeuticz Private Limited - Company Profile

It is a pharma private limited company based in Surat, Gujarat, India, established in 2020.

2020 | Surat, Gujarat, India | Active
Last Updated:

About Sanguine Therapeuticz Private Limited

Sanguine Therapeuticz Private Limited, a active private limited company, was established on 12 August 2020 in Surat, Gujarat, India. Engaging in api manufacturers within the pharma sector, it holds CIN: U24100GJ2020PTC115481. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹7.01 Cr and a paid-up capital of ₹7.00 Cr.

It upholds a compliant status. Employing 9 professional, Its leadership includes Rakesh Agarwal (Director), Alkesh Pramodbhai Rami (Director), Mukesh Agarwal (Director). It holds ₹40.62 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 237, Shyam Sangini Textile Market Nr. Kumbharia, Saroli, Surat, Gujarat, 395010.

Company Details

  • CIN/LLPIN

    U24100GJ2020PTC115481

  • Registration Number

    115481

  • Incorporation Date

    12 August 2020

  • Authorized Capital

    ₹7.01 Cr

  • Paid-Up Capital

    ₹7.00 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Indicators

  • Authorised Capital ₹ 7.01 Cr
  • Paid Up Capital ₹ 7.00 Cr
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 40.62 Cr
  • Revenue Growth -78.57%
  • Profit Growth 100.59%
  • Ebitda 97.88%
  • Net Worth 77.01%
  • Total Assets 52.26%
Company report

Sanguine Therapeuticz Private Limited

Company Report FY 2025-2026

Explore comprehensive insights into Sanguine Therapeuticz Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element

Who are the key members and board of directors at Sanguine Therapeuticz Private Limited?

Current Directors

NameDesignationAppointment DateStatus
Rakesh AgarwalDirector12 Aug 2020Current
Alkesh Pramodbhai RamiDirector20 Jul 2021Current
Mukesh AgarwalDirector12 Aug 2020Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sanguine Therapeuticz.

Sanguine Therapeuticz Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 78.57% decrease. The company also saw a substantial improvement in profitability, with a 100.59% increase in profit. The company's net worth Soared by an impressive increase of 77.01%.

Sanguine Therapeuticz revenue growth over time
Sanguine Therapeuticz profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-78.57%
Revenue from Operations
Total Assets
52.26%
Profit or Loss
100.59%
Net Worth
77.01%
EBITDA
97.88%

What is the Ownership and Shareholding Structure of Sanguine Therapeuticz?

In 2023, Sanguine Therapeuticz had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹406,200,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Others : 40.00 Cr
  • Uco Bank : 0.62 Cr

Latest Charge Details

DateLenderAmountStatus
21 Sep 2024Uco Bank₹6.20 MOpen
22 Dec 2021Others₹20.00 CrOpen
14 Dec 2021Others₹20.00 CrOpen

Explore comprehensive loan charge details -

How Many Employees Work at Sanguine Therapeuticz?

Sanguine Therapeuticz has a workforce of 9 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Sanguine Therapeuticz Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sanguine Therapeuticz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanguine Therapeuticz's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sanguine Therapeuticz

Recent Activity within the Organization

  • Annual General Meeting

    Sanguine Therapeuticz Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with Uco Bank amounted to Rs. 0.62 Cr with Charge ID 100978224 was registered on 21 Sep 2024. was documented.

  • Balance Sheet

    Progress on Sanguine Therapeuticz Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100515094 was registered on 22 Dec 2021. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100515090 was registered on 14 Dec 2021. was documented.

  • Director Appointment

    Progress on Alkesh Pramodbhai Rami was appointed as a Director was appointed as a Director on 20 Jul 2021 & has been associated with this company since 4 years 4 months . was documented.

Frequently Asked Questions

  • What is the CIN of Sanguine Therapeuticz Private Limited?

    The CIN of Sanguine Therapeuticz Private Limited is U24100GJ2020PTC115481.

  • Where is Sanguine Therapeuticz Private Limited headquartered?

    Sanguine Therapeuticz Private Limited is headquartered at 237, Shyam Sangini Textile Market Nr. Kumbharia, Saroli, Surat, Gujarat, 395010.

  • When was Sanguine Therapeuticz Private Limited incorporated?

    Sanguine Therapeuticz Private Limited was incorporated on 12 August 2020.

  • Who are the current directors of Sanguine Therapeuticz Private Limited?

    The current directors of Sanguine Therapeuticz Private Limited are

  • What is the primary industry of Sanguine Therapeuticz Private Limited?

    The primary industry of Sanguine Therapeuticz Private Limited is Pharma.

  • Is Sanguine Therapeuticz Private Limited a listed company?

    Sanguine Therapeuticz Private Limited is unlisted.

  • What is the capital structure of Sanguine Therapeuticz Private Limited?

    The authorized capital of Sanguine Therapeuticz Private Limited is ₹7.01 Cr, and the paid-up capital is ₹7.00 Cr.

  • What is the compliance status of Sanguine Therapeuticz Private Limited?

    The compliance status of Sanguine Therapeuticz Private Limited is Compliant.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial